Literature DB >> 18832838

Precise role of acid in non-erosive reflux disease.

Changcheng Wang1, Richard H Hunt.   

Abstract

The fundamental abnormality in gastroesophageal reflux disease is exposure of the esophageal epithelium to acidic gastric contents, resulting in histopathologic injury and/or symptoms. With increasing understanding of gastroesophageal reflux disease, non-erosive reflux disease (NERD) is found to account for >50% of cases involving gastroesophageal reflux. There is a good correlation between esophageal acid exposure (EAE) and endoscopic changes. Duration of EAE correlates with severity of erosive esophagitis (EE), and the number of prolonged acid reflux episodes and esophageal exposure to acid and pepsin is increased in more severe reflux. However, there is no convincing evidence to support a significant difference in the acid secretory capacity between patients with NERD or EE. Although acid reflux gives rise to similar symptoms in both NERD and EE patients, the underlying mechanism of acid injury may be different. Dilated intercellular spaces may be responsible for the enhanced perception of proximal acid reflux and dilated intercellular spaces are a feature of NERD patients, irrespective of EAE, and can be considered an objective, structural marker of reflux symptoms. Three different mechanisms have been proposed to explain the occurrence of heartburn in endoscopy-negative patients: esophageal visceral hypersensitivity, sustained esophageal contractions, and abnormal tissue resistance. Impaired esophageal mucosal resistance or increased sensitivity, even to small amounts of acid reflux, plays a key role in the pathophysiology of NERD. Moreover, hyperalgesia may be a predominant mechanism in eliciting symptoms in NERD patients. Increasingly seen are patients with a poor response to acid suppression treatment. Moreover, even double proton pump inhibitor dosing does not completely inhibit gastric acid secretion and relieve all symptoms. Thus, current definitions of acid reflux require review to increase the sensitivity to determine the frequency and implication of short periods of acidity in the esophagus. Analysis such as analysis of the area under the H(+) activity time curve is one alternative approach for evaluating acid secretion. The precise role of acid in NERD needs further clarification. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832838     DOI: 10.1159/000151253

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  5 in total

Review 1.  Proton pump inhibitor for non-erosive reflux disease: a meta-analysis.

Authors:  Ji-Xiang Zhang; Meng-Yao Ji; Jia Song; Hong-Bo Lei; Shi Qiu; Jing Wang; Ming-Hua Ai; Jun Wang; Xiao-Guang Lv; Zi-Rong Yang; Wei-Guo Dong
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

2.  Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus.

Authors:  Guilherme Pretto; Richard Ricachenevsky Gurski; Marcelo Binato; Daniel Navarini; Wolfgan William Schmidt Aguiar; Luise Meurer
Journal:  Dig Dis Sci       Date:  2012-08-09       Impact factor: 3.199

3.  Orally administered L-arginine and glycine are highly effective against acid reflux esophagitis in rats.

Authors:  Kenji Nagahama; Hikaru Nishio; Masanori Yamato; Koji Takeuchi
Journal:  Med Sci Monit       Date:  2012-01

4.  Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship?

Authors:  Uday C Ghoshal; Dipti Chourasia
Journal:  J Neurogastroenterol Motil       Date:  2010-07-27       Impact factor: 4.924

5.  Alleviation of ascorbic acid-induced gastric high acidity by calcium ascorbate in vitro and in vivo.

Authors:  Joon-Kyung Lee; Sang-Hyuk Jung; Sang-Eun Lee; Joo-Hui Han; Eunji Jo; Hyun-Soo Park; Kyung-Sun Heo; Deasun Kim; Jeong-Sook Park; Chang-Seon Myung
Journal:  Korean J Physiol Pharmacol       Date:  2017-12-22       Impact factor: 2.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.